27% profits every 20 days?
This is what Nic Chahine averages with his options buys. Not selling covered calls or spreads... BUYING options. Most traders don't even have a winning percentage of 27% buying options. He has an 83% win rate. Here's how he does it.
Mallinckrodt (NYSE:MNK) shares are trading higher on Wednesday.
The company announced it received clearance from Health Canada to start on a pilot trial of high dose inhaled nitric oxide therapy for coronavirus infection and associated lung complications.
Mallinckrodt is a manufacturer of specialty pharmaceuticals, generic drugs and imaging agents.
Mallinckrodt's stock was trading up 16% to $2.30 per share in Wednesday’s pre-market session. The stock has a 52-week high of $23.90 and a 52-week low of $1.
Related Links:
Mallinckrodt Plummets On Report Of Possible Generics Business Bankruptcy
Mallinckrodt To Sell BioVectra To HIG Capital For $250M
27% profits every 20 days?
This is what Nic Chahine averages with his options buys. Not selling covered calls or spreads... BUYING options. Most traders don't even have a winning percentage of 27% buying options. He has an 83% win rate. Here's how he does it.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!